Home
Law & Policy

Topic: Law & Policy

The EPO and UKIPO approaches to AI and patentable subject matter

Co-published - Although the UK is a member of the European Patent Organisation, there are ways in which the two agencies differ in how they look at granting protection in the field

The Western District of Texas is a problem, but not for the reasons you think

Saturday Opinion: the popularity of Judge Alan Albright’s court as a venue for plaintiffs in patent cases comes down to so many of them not feeling they have a fair chance elsewhere

Without injunctions, the US patent system is rigged in favour of deep pocket defendants

Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions

Latest content

Skinny label concerns persist for generics, despite good news from Delaware

A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs

14 January 2022

The EU’s patent attorney deficit is a major hindrance to innovation leadership

A new scheme launched yesterday offers finding to SMEs seeking to protect their inventions but does little to tackle what is a major problem in many member states

11 January 2022

Tencent, Vivo among biggest risers as Chinese patent grants continue to grow

The number of invention patents and utility models issued by the CNIPA both surged by more than 30% last year, while PCT filings levelled off

11 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

Vidal USPTO Director confirmation vote cancelled, but not due to opposition to her appointment

The Senate Judiciary Committee is all set to endorse her appointment but has been delayed in doing thanks to a funeral and a riot’s anniversary

06 January 2022

Landmark Dutch appeal court decision reduces risk of third-party damages against pharma patentees

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

How looming patent cliffs are impacting pharma IP strategies

Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.

05 January 2022

Huawei inks its first Wi-Fi 6 patent licence with an overseas implementer

Latest patent deals related to the next-gen wireless internet standard suggest patent owners spy monetisation opportunities

04 January 2022

What’s ahead for the global IP market in 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022

The US's biggest patent stories of 2021

Kathi Vidal, Ericsson, Arthrex and Judge Alan Albright were among the names that made the IP headlines over the course of the year

23 December 2021

Get unlimited access to all IAM content